• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与呼吸窘迫非致命性进展相关的ABCA3杂合突变

Heterozygous ABCA3 mutation associated with non-fatal evolution of respiratory distress.

作者信息

Yokota Takuya, Matsumura Yoshihiro, Ban Nobuhiro, Matsubayashi Tadashi, Inagaki Nobuya

机构信息

Department of Pediatrics, Seirei Hamamatsu General Hospital, Shizuoka 430-8558, Japan.

出版信息

Eur J Pediatr. 2008 Jun;167(6):691-3. doi: 10.1007/s00431-007-0542-8. Epub 2007 Jul 6.

DOI:10.1007/s00431-007-0542-8
PMID:17618459
Abstract

A boy without symptoms up to 12 months of age started with persisting cough followed by respiratory failure at 18 months of age, resulting in mechanical ventilation because of alveolar proteinosis. Lung biopsy showed PAS-positive material. PCR was negative for CMV, Pneumocystis jiroveci and adenovirus. BALF showed mature SP-B. Analysis of the ATP-binding cassette transporter A3 (ABCA3; OMIM 601615) gene showed a compound heterozygous mutation from paternal W1148X and maternal T1114A. Alveolar lavage with 720 mg of bovine surfactant allowed weaning from ventilator support. Heterozygous mutation in the ABCA3 gene could be associated with a milder evolution as compared to the homozygous frequently lethal evolution.

摘要

一名12个月大前无症状的男孩,18个月大时开始持续咳嗽,随后因肺泡蛋白沉积症导致呼吸衰竭,需要机械通气。肺活检显示PAS阳性物质。巨细胞病毒、耶氏肺孢子菌和腺病毒的聚合酶链反应检测均为阴性。支气管肺泡灌洗液显示有成熟的表面活性蛋白B。对ATP结合盒转运体A3(ABCA3;OMIM 601615)基因的分析显示,存在来自父亲的W1148X和来自母亲的T1114A的复合杂合突变。用720毫克牛肺表面活性剂进行肺泡灌洗后,患儿得以脱机。与通常致命的纯合子情况相比,ABCA3基因的杂合突变可能与病情进展较缓和有关。

相似文献

1
Heterozygous ABCA3 mutation associated with non-fatal evolution of respiratory distress.与呼吸窘迫非致命性进展相关的ABCA3杂合突变
Eur J Pediatr. 2008 Jun;167(6):691-3. doi: 10.1007/s00431-007-0542-8. Epub 2007 Jul 6.
2
Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.婴幼儿和儿童遗传性弥漫性肺疾病的超微结构特征:一项队列研究及综述
Ultrastruct Pathol. 2013 Oct;37(5):356-65. doi: 10.3109/01913123.2013.811454.
3
[Pulmonary surfactant protein adenosine triphosphate-binding-cassette-A3 gene composite mutations in infant congenital interstitial lung disease: report of a case and review of literature].[婴儿先天性间质性肺疾病中肺表面活性物质蛋白三磷酸腺苷结合盒式转运体A3基因复合突变:1例报告并文献复习]
Zhonghua Er Ke Za Zhi. 2016 Oct 2;54(10):761-766. doi: 10.3760/cma.j.issn.0578-1310.2016.10.010.
4
Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.两兄弟的间质性肺病与新型复合杂合 ABCA3 突变。
Eur J Pediatr. 2013 Jul;172(7):953-7. doi: 10.1007/s00431-013-1977-8. Epub 2013 Feb 27.
5
[Clinical analysis of heterozygous ABCA3 mutations in children].儿童ABCA3基因杂合突变的临床分析
Zhonghua Er Ke Za Zhi. 2014 Apr;52(4):244-7.
6
Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation.由一种新型ABCA3突变引起的致命性新生儿间质性肺炎的超微结构和分子分析
Mod Pathol. 2007 Oct;20(10):1009-18. doi: 10.1038/modpathol.3800928. Epub 2007 Jul 27.
7
ABCA3 gene mutations in newborns with fatal surfactant deficiency.患有致命性表面活性物质缺乏症的新生儿中的ABCA3基因突变。
N Engl J Med. 2004 Mar 25;350(13):1296-303. doi: 10.1056/NEJMoa032178.
8
Neonatal respiratory insufficiency caused by an (homozygous) ABCA3-stop mutation: a systematic evaluation of therapeutic options.由(纯合子)ABCA3 终止突变引起的新生儿呼吸功能不全:治疗选择的系统评估。
Klin Padiatr. 2014 Apr;226(2):53-8. doi: 10.1055/s-0033-1363687. Epub 2014 Mar 14.
9
New ATP-binding cassette A3 mutation causing surfactant metabolism dysfunction pulmonary type 3.导致3型表面活性剂代谢功能障碍性肺病的新型ATP结合盒转运蛋白A3突变
Pediatr Int. 2015 Oct;57(5):970-4. doi: 10.1111/ped.12673. Epub 2015 Aug 19.
10
Lung disease caused by mutations.由 突变引起的肺部疾病。
Thorax. 2017 Mar;72(3):213-220. doi: 10.1136/thoraxjnl-2016-208649. Epub 2016 Aug 11.

引用本文的文献

1
ABCA3 Deficiency-Variant-Specific Response to Hydroxychloroquine.ABCA3 缺陷型对羟氯喹的反应。
Int J Mol Sci. 2023 May 3;24(9):8179. doi: 10.3390/ijms24098179.
2
ABCA3-related interstitial lung disease beyond infancy.ABCA3 相关的间质性肺病不只是发生在婴儿期。
Thorax. 2023 Jun;78(6):587-595. doi: 10.1136/thorax-2022-219434. Epub 2023 Feb 20.
3
Systematic review of drug effects in humans and models with surfactant-processing disease.系统评价表面活性剂处理疾病患者和模型中的药物作用。

本文引用的文献

1
Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency.致命性表面活性剂缺乏中ATP结合盒转运体ABCA3突变体的特征与分类
J Biol Chem. 2006 Nov 10;281(45):34503-14. doi: 10.1074/jbc.M600071200. Epub 2006 Sep 7.
2
Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency.足月遗传性ABCA3缺乏婴儿肺表面活性物质系统的改变。
Am J Respir Crit Care Med. 2006 Sep 1;174(5):571-80. doi: 10.1164/rccm.200509-1535OC. Epub 2006 May 25.
3
Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles.
Eur Respir Rev. 2018 Jul 11;27(149). doi: 10.1183/16000617.0135-2017. Print 2018 Sep 30.
4
Different course of lung disease in two siblings with novel ABCA3 mutations.两名患有新型ABCA3突变的兄弟姐妹的肺部疾病病程不同。
Eur J Pediatr. 2014 Dec;173(12):1553-6. doi: 10.1007/s00431-013-2087-3. Epub 2013 Jul 12.
5
Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.两兄弟的间质性肺病与新型复合杂合 ABCA3 突变。
Eur J Pediatr. 2013 Jul;172(7):953-7. doi: 10.1007/s00431-013-1977-8. Epub 2013 Feb 27.
6
A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration.大脑脂质稳态与神经退行性变中的 A 亚类 ATP 结合盒蛋白
Front Psychiatry. 2012 Mar 5;3:17. doi: 10.3389/fpsyt.2012.00017. eCollection 2012.
7
Genetic interstitial lung disease.遗传性肺间质疾病。
Clin Chest Med. 2012 Mar;33(1):95-110. doi: 10.1016/j.ccm.2011.11.001. Epub 2011 Dec 6.
8
Genetic Basis of Children's Interstitial Lung Disease.儿童间质性肺疾病的遗传基础
Pediatr Allergy Immunol Pulmonol. 2010 Mar;23(1):15-24. doi: 10.1089/ped.2009.0024.
9
Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1.人溶血磷脂酰胆碱酰基转移酶 1 合成磷脂酰胆碱。
J Lipid Res. 2009 Sep;50(9):1824-31. doi: 10.1194/jlr.M800500-JLR200. Epub 2009 Apr 21.
10
Genetic disorders of surfactant dysfunction.表面活性剂功能障碍的遗传性疾病。
Pediatr Dev Pathol. 2009 Jul-Aug;12(4):253-74. doi: 10.2350/09-01-0586.1.
人类ABCA3是新生儿致命性表面活性剂缺乏症相关基因abca3的产物,具有独特的ATP水解活性并能产生细胞内多层囊泡。
Biochem Biophys Res Commun. 2004 Nov 5;324(1):262-8. doi: 10.1016/j.bbrc.2004.09.043.
4
ABCA3 gene mutations in newborns with fatal surfactant deficiency.患有致命性表面活性物质缺乏症的新生儿中的ABCA3基因突变。
N Engl J Med. 2004 Mar 25;350(13):1296-303. doi: 10.1056/NEJMoa032178.
5
ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells.ABCA3是人类肺II型肺泡细胞中的一种板层小体膜蛋白。
FEBS Lett. 2001 Nov 16;508(2):221-5. doi: 10.1016/s0014-5793(01)03056-3.
6
Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.肺泡蛋白沉积症患者血清及支气管肺泡灌洗液中KL-6水平
Am J Respir Crit Care Med. 1998 Oct;158(4):1294-8. doi: 10.1164/ajrccm.158.4.9712003.